Adverse events of targeted therapies reported by patients with cancer treated in primary care

BACKGROUND: Targeted Therapies (TT) are among the therapeutic innovations for cancer treatment in outpatient settings. TT-related Adverse Events (AEs) are a source of loss of opportunity for patients if their management is inappropriate. OBJECTIVES: The objective of this study was to describe the AE...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Samuel, Edeline, Julien, Campillo-Gimenez, Boris, Ventroux, Elodie, Rouge-Bugat, Marie-Eve, Chapron, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801082/
https://www.ncbi.nlm.nih.gov/pubmed/33399025
http://dx.doi.org/10.1080/13814788.2020.1846713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801082/
https://www.ncbi.nlm.nih.gov/pubmed/33399025
http://dx.doi.org/10.1080/13814788.2020.1846713

Ejemplares similares